• Silynx, producer of field-tested, certified, and combat-proven in-ear tactical communication headset systems, offers clear communication and situational awareness, along with hearing protection, to clients across multiple sectors including military, law enforcement, sport shooting, industrial, and riot control.
• The company’s tactical headsets are built on proprietary technologies that offer a blend of protection, communication, and comfort for operators who don’t compromise on effectiveness, comfort, and overall quality.
• Full tactical communication systems offer Silynx Drone Detection providing the ability to better hear and act upon distant drone activity
• Silynx world sales continue to expand, including a recent $3 million order of advanced tactical communication solutions in Asia, and selection as a final bidder for two major U.S. DOD programs.

Whether you’re on the battlefield, in a tense SWAT operation, or working in a loud factory, hearing protection that keeps you safe, but doesn’t hurt your ability to hear your surroundings and communicate with others, is crucial to your success and comfort. Without an effective solution, you can miss critical commands, warnings, or other vital information, or can permanently damage your hearing.

Silynxcom (NYSE American: SYNX) has the mission of creating certified and field-tested in-ear communication headsets that not only offer hearing protection, but also ensure consistent communication and situational awareness.

The company develops, designs, and manufactures rugged tactical and commercial communication headsets, currently selling them to hundreds of customers across more than 40 countries, for military, law enforcement, shooting sport, industrial, and riot control application. Importantly, Silynx works directly with end users for valuable feedback to continually drive design decisions and improvements. As a result, the company has customers that have provided recurring orders for years. There’s a rapidly-growing market for superior quality tactical in-ear headsets, versus traditional over-ear designs, and Silynx is creating a first-mover advantage in the space.

Silynx’s tactical communication headsets are built on three proprietary technologies and certification standards:

• First, the TRUE VOICE in-ear microphone captures voice from inside the ear canal with “Talking from the Ear” microphone technology, eliminating the need for boom mics or throat mics, while reducing wind noise.
• Next, there’s the HearThru electronic ambient pass-through technology, which offers situational awareness by picking up environmental sounds through external mics, and playing it back through the in-ear speakers at an adjustable volume.
• For certifications, there is MIL-STD-810, covering environmental/ruggedness testing (temperature, shock, humidity, immersion).  In addition, it provides an NRR (Noise Reduction Rating) in accordance with ANSI S3.19, achieving one of the highest ratings in the in-ear tactical hearing protection category.

Silynx headsets are also waterproof (with an IP68 rating, tested for immersion), as well as being incredibly light, at under 5 grams per earbud. They are also small enough to easily fit under helmets, riot visors, gas masks, and ballistic eyewear, and feature wide compatibility with radio, intercom systems, and smartphones. 

Silynx offers a full scope of products and accessories to fit a range of needs, including in-ear sound protection headsets, sound protection radio controllers, single-side headsets, over-the-ear sound protection headsets, active sound protection plugs, wired and wireless push-to-talk (“PTT”), and more. 

The company also provides entire tactical communication systems, combining rugged and waterproof command units, in-ear headsets, and a variety of cables and adapters. These systems also come with Silynx Drone Detection, an industry-first capability, which is an audio enhancement mode designed to help hear distant drone activity quicker and more clearly.

Silynx continues to expand sales operations and activities in numerous regions, including Asia and Central Europe, fulfilling a growing list of orders, including a recent $3 million order of advanced tactical communication solutions to a prominent military customer in Asia (https://ibn.fm/44UPO).

In addition, the company has partnered with leading international manufacturers, engaging with emergency services and first responder agencies. 

For more information, visit the Silynx website at https://silynxcom.com.

NOTE TO INVESTORS: The latest news and updates relating to SYNX are available in the company’s newsroom at https://ibn.fm/SYNX

• India’s medical-device market is projected to grow from $15.2 billion in 2025 to $50.1 billion by 2030, with the possible 26.9% CAGR creating a significant domestic and export opportunity for Indian medical-device manufacturers.
• SS Innovations is already commercializing the SSi Mantra surgical robotic system from its Indian base, having installed 224 SSi Mantra systems across 12 countries by June 30, providing an established platform as India expands its MedTech manufacturing ambitions.
• For SSII, India’s push to reduce medical-device import dependence could create opportunities extending beyond domestic sales into manufacturing, exports, and international technology adoption.
• The company is actively seeking both US FDA clearance and European Union CE mark certification to expand its flagship SSi Mantra surgical robotic system globally.

India’s next major manufacturing opportunity may emerge not from information technology or semiconductors, but from medical devices. An observation from business developer Shaad Merchant, quoting a recent report from Rubix Industry Insights, shows India’s medical-device market projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, representing a compound annual growth rate of 26.9%. That projected expansion would place medical devices among India’s faster-growing industrial and healthcare segments (https://ibn.fm/19Onj).

The timing is particularly relevant for SS Innovations International (NASDAQ: SSII), which is developing and commercializing surgical robotic technology from India while expanding the international footprint of its SSi Mantra system.

The opportunity is not limited to market consumption. India is also seeking to increase its domestic manufacturing capacity and reduce dependence on imported medical technology. The Rubix report said medical-device exports reached $4.1 billion in fiscal 2025, while imports were approximately $8.6 billion, and estimated that 70% to 80% of domestic medical-device demand is still met through imports, particularly for technologically advanced products.

India currently ranks as the fourth-largest medical-device market in Asia and among the world’s top 20, according to the Rubix report. The government has introduced several initiatives intended to strengthen the domestic ecosystem, including the National Medical Devices Policy, Production Linked Incentive Scheme, the Scheme for Promotion of Medical Devices Parks and MedTech Mitra. The broader policy objective is to increase India’s share of the global medical-device market from approximately 1.6% toward 12% over the coming years.

Unlike some areas of healthcare, sophisticated medical equipment can also create industrial capabilities that extend across multiple markets. Manufacturing robotic surgical systems, for example, requires expertise in precision engineering, software, electronics, imaging, instrumentation and systems integration.

SS Innovations is already building that type of capability around its SSi Mantra platform. The company is not simply participating in India’s medical-device market as a distributor of imported equipment. Its SSi Mantra is a proprietary surgical robotic system developed for use across multiple specialties, including cardiac surgery.

The opportunity becomes more relevant when viewed alongside SSII’s recent financial performance. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million in the second quarter of 2025. Gross profit increased 20% to $7.1 million. For the first six months of 2026, revenue reached $25.0 million, up 65.6% from $15.1 million in the comparable period. Gross profit increased 77.5% to $12.4 million, while first-half gross margin improved to 49.6%.

System installations provide another measure of the company’s progress. SS Innovations installed 30 SSi Mantra systems during the second quarter, compared with 23 a year earlier. First-half installations reached 56, versus 38 during the first half of 2025. By June 30, the cumulative installed base had reached 224 systems across 12 countries. Those systems had been used in 12,272 surgeries, including 175 telesurgeries, 637 cardiac procedures and 222 pediatric procedures. That installed base gives SSII an important starting point as India develops its medical-device manufacturing ecosystem.

The SSi Mantra is a modular surgical robotic system with three to five robotic arms, an ergonomic surgeon command center and a 3D 4K display. Its instrument portfolio is designed to support multiple surgical specialties.

SSII has also continued to develop telesurgery capabilities. In April, the company hosted the Global Multi-Specialty Robotic Surgery Conference in New Delhi, attracting more than 1,600 attendees in person and 1,800 virtual participants from 19 countries, according to the company.

In May, surgeons completed a telesurgery between Australia and India using the SSi Mantra. In June, the company announced a robotic-assisted cardiac procedure conducted between Guyana and India across approximately 12,500 miles of fiber-network distance. After the second quarter ended, SSII announced another long-distance telesurgery. On July 29, surgeons led by CEO Dr. Sudhir Srivastava performed a robotic sleeve gastrectomy between Colombia and India across more than 13,600 miles of fiber-network distance.

Ultimately, India’s medical-device expansion may help companies such as SS Innovations build scale beyond the domestic market. The United States and Germany are already among India’s key medical-device export destinations, while the U.S. and China are major sources of imports, according to the Rubix report.

For SSII, that creates a potential two-stage opportunity. The first is to deepen its position in India as the country expands access to advanced medical technology. The second is to use India’s manufacturing and engineering base as a platform for international expansion, especially in underserved countries and aiming for entry into the United States and European Union, according to recent comments by Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations. 

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation.
• Nanox is expanding its commercial reach through its U.S. commercial activities and collaboration with healthcare organizations.
• First-quarter 2026 revenue increased to $4.3 million from $2.8 million in the prior-year period, with contributions from teleradiology, imaging systems, OEM services, AI, software and Health IT.
• Nanox has secured FDA clearance for Nanox.ARC, Nanox.ARC X and three Nanox.AI medical imaging solutions, while its commercial and clinical activities involve organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital.

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.

Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

Technology and Services

Nanox.ARC

Nanox.ARC is an FDA-cleared and CE-marked stationary digital multi-source tomosynthesis system that produces three-dimensional radiographic images while reducing the superimposition of anatomical structures. The company offers the system through a capital-purchase model or a pay-per-scan medical screening-as-a-service (“MSaaS”) model that does not require an upfront capital expenditure.

Nanox.ARC X is the company’s next-generation, FDA-cleared system, combining a compact 15-by-10-foot space requirement and standard 110-volt power connection with the ability to generate up to 200 coronal images per scan. According to Nanox, the system delivers approximately 80% less radiation than a CT scan, can be billed under CPT code 76100 and is designed to receive future capabilities remotely following applicable regulatory clearance.

A Nanox.ARC system was also in commercial use and integrated into routine clinical workflow at a RadNet facility.

Nanox.AI

Nanox.AI is the deep-learning medical imaging analytics subsidiary of Nanox. Nanox.AI solutions are developed to target highly prevalent chronic and acute diseases affecting large populations around the world. Leveraging AI, Nanox.AI helps clinicians extract valuable and actionable clinical insights from medical imaging that otherwise may go unnoticed, potentially initiating further medical assessment to establish individual preventative care pathways for patients. Nanox states that its AI technology draws on 30 million patient records, 10 years of patient history and 500 million images across multiple imaging modalities. In one reported deployment, Corewell Health used the cardiac solution to identify nearly 4,000 new patients with coronary artery calcification in 2023, compared with 268 patients whose calcification had been reported during the preceding two years.

In July 2026, Nanox announced that data from studies involving Brigham and Women’s Hospital, Massachusetts General Hospital, the University of Texas Southwestern Medical Center and other institutions would be presented at the Society of Cardiovascular Computed Tomography’s annual scientific meeting. The studies evaluated HealthCCSng’s agreement with expert assessment and whether AI-detected coronary calcium could help clinicians identify opportunities for preventive lipid-lowering therapy.

Nanox.CLOUD

Nanox.CLOUD supports image processing, radiology services and Nanox.ARC fleet management through capabilities including cloud-based image reconstruction, centralized protocol management, continuous updates and remote support. The platform can be hosted locally or in the cloud and is designed for HIPAA and GDPR compliance.

Other Technology and Services

The remainder of the Nanox ecosystem includes USARAD’s teleradiology services, Nanox.MARKETPLACE’s web-based connection of imaging facilities with diagnostic expertise, and Nanox Health IT’s healthcare IT solutions, including RIS, PACS, AI, dictation and secure infrastructure offerings.

Nanox also offers its proprietary cold-cathode X-ray source and tube technology, a core component of the company’s imaging platform, to original equipment manufacturers through hardware, licensing and royalty arrangements for potential medical, industrial and security applications.

Leadership Team

Erez Meltzer, Chief Executive Officer and Acting Chairman of the Board, leads Nanox after previously serving for six years as chairman of Hadassah Medical Center in Israel. His career also includes leadership roles at Gadot Chemicals & Shipping Group, Africa Israel, Netafim and Creo Scitex.

Guy Nathanzon, Chief Financial Officer, has held senior CFO and COO positions at U.S. publicly traded companies and medical technology businesses, with experience supporting commercialization, organizational growth and global operations. He previously served as CFO of AI-based medical diagnostics company Scopio Labs and most recently served as CFO of New York Stock Exchange-listed Valens Semiconductor.

For more information, visit the company’s website at www.Nanox.vision.

NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at https://ibn.fm/NNOX

• MindWave Innovations is developing institutional-grade digital asset infrastructure designed to help corporations and institutions hold, manage and generate yield from Bitcoin reserves while combining traditional financial controls with blockchain efficiency.
• The company is expanding access to its ecosystem, with its native $NILA token now available to eligible U.S. users through Webot, providing a regulated pathway into the broader MindWaveDAO ecosystem.
• The expansion is expected to continue with the October 2026 launch of MindChain, an independent Layer 2 blockchain that MindWave describes as the world’s first fully insured blockchain and a foundation for broader ecosystem development and real-world asset tokenization.

As digital assets mature, the opportunity is increasingly extending beyond simply owning cryptocurrency. For corporations and institutional investors, the next challenge is building infrastructure that can help manage digital assets, generate potential returns and maintain appropriate financial controls.

MindWave Innovations (NYSE American: APUS) is positioning itself around that transition. The digital asset and technology company offers institutional-grade treasury infrastructure designed to help corporations and institutional investors hold, manage and generate yield from Bitcoin reserves. Its approach combines elements of traditional financial infrastructure, including custody and reporting, with blockchain-based transparency and efficiency.

The company’s strategy extends beyond Bitcoin treasury management. Through MindWaveDAO, the company is developing an interconnected ecosystem that brings together treasury infrastructure, AI-enabled yield capabilities, blockchain technology, tokenization, staking and governance.

From Bitcoin Treasury to Broader Digital Infrastructure

MindWave’s August 2026 Ecosystem Journal positions treasury management as a foundation for broader ecosystem development, with the company emphasizing areas including infrastructure, interoperability, real-world asset tokenization, governance and $NILA utility.

Rather than treating these capabilities as standalone products, MindWave is positioning them as complementary components of a broader digital financial system. Bitcoin treasury infrastructure provides the financial foundation, while blockchain infrastructure and tokenization are intended to create additional opportunities for participation and application development.

At the center of that model is $NILA, the ecosystem’s native token. The token is designed to support activities including staking, governance and access to ecosystem services, giving it a role beyond simply functioning as a digital asset.

That strategy is beginning to translate into tangible expansion. As of August 3, 2026, $NILA became available to eligible U.S. users through Webot, giving participants a regulated pathway to access the token and the broader ecosystem.

The move represents more than another trading venue. It expands MindWave’s reach into a strategically important market while reinforcing the company’s emphasis on regulated access and responsible ecosystem development.

MindChain Creates the Next Layer

The next major milestone is the anticipated October 2026 launch of MindChain.

MindWave describes MindChain as the world’s first fully insured blockchain. The network is being developed as an independent Layer 2 built on a Nitro-compatible execution stack and compatible with the Ethereum Virtual Machine (“EVM”). The company says the network will use Ethereum for settlement and data availability while providing faster transaction execution.

The network is also designed to support application-specific subnets, EVM-compatible development tools and cross-chain interoperability. These capabilities are intended to give developers and institutions a flexible infrastructure for building applications while maintaining connections with the broader blockchain ecosystem.

Real-world asset tokenization is an important part of that opportunity. As financial institutions increasingly explore bringing assets such as funds, securities, commodities and other real-world value onto blockchain networks, the need for infrastructure capable of supporting those applications is growing.

MindChain is being positioned to provide that infrastructure within the MindWave ecosystem.

The Transition to MindChain

MindChain will also change the role of $NILA. Currently deployed on BNB Chain, the token is expected to become the native asset of MindChain following the network’s launch, supporting transaction fees, staking and validator participation.

Existing holders are expected to have access to a dedicated Migration Portal to transition from the current BNB Chain token to native $NILA. 

The transition would give $NILA a more direct relationship with the infrastructure supporting the broader ecosystem. Rather than functioning solely as a token within an existing network, it is designed to become part of the operating layer of MindChain itself.

This makes the timing of the Webot expansion particularly relevant. The August milestone broadens access to $NILA ahead of the planned October launch, while MindChain is intended to provide the infrastructure for its next phase of utility.

Building an Institutional Digital Economy

The broader opportunity for MindWave is the convergence of digital assets, institutional finance and blockchain infrastructure.

As companies become more comfortable holding Bitcoin and other digital assets, demand may increasingly shift toward the systems that help institutions manage those assets, generate potential returns and connect them with additional financial applications.

MindWave is attempting to address that opportunity through an ecosystem that connects Bitcoin treasury management with yield generation, governance, staking, tokenization and dedicated blockchain infrastructure.

The availability of $NILA to eligible U.S. users through Webot and the anticipated October 2026 launch of MindChain represent two important milestones in that strategy. The first expands access to the ecosystem, while the second is intended to provide the underlying infrastructure for its next phase of development.

If MindWave executes on its roadmap, the next stage will be less about establishing individual components and more about demonstrating how those components can work together to support institutions, developers and participants across a growing digital financial economy.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

• The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without introducing sulfur into the process.
• FASCarbon(TM) is the solid carbon output of Frontieras’s FASForm(TM) process, a continuous solid carbon fractionation system that thermally cracks coal without combustion.
• FASCarbon’s low sulfur content makes it a direct substitute for higher-grade, more expensive carbon inputs in steelmaking and industrial heating applications.

Coal has always been valued for what it produces when burned. Frontieras North America has built a business around what it produces when it isn’t burned. The company’s FASForm(TM) process fractionates coal into its molecular components without combustion, generating diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid, and FASCarbon(TM), a solid carbon product with sulfur content below 1%. That specification puts Frontieras directly inside the industrial carbon market that steel manufacturers, cement producers and heavy industrial operators depend on, and that consistently rewards suppliers who can deliver cleaner, more consistent carbon inputs.

The industrial carbon market is already large and growing fast. The global petroleum coke market, the primary reference point for industrial carbon products, was valued at approximately $35.5 billion in 2025 and is projected to reach $68.82 billion by 2030. Steel production is one of the primary drivers. Global crude steel output reached approximately 1.92 billion metric tons in 2023, and the carbon inputs required to produce it represent a persistent, infrastructure-driven demand.

The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without introducing sulfur into the process. Sulfur content in petroleum coke ranges from roughly 0.5% to 6%, depending on the feedstock and refining process. High sulfur levels restrict how petcoke can be used. In steel manufacturing, sulfur contaminates the melt and degrades the quality of finished metal. In some instances, such as electrode production for electric arc furnaces, low sulfur content is a hard requirement. Fuel-grade petcoke with elevated sulfur faces increasing regulatory scrutiny in combustion applications. The market consistently assigns a premium to lower-sulfur carbon products because they are more useful across more applications.

This is the market position that FASCarbon occupies. FASCarbon is the solid carbon output of Frontieras’s FASForm process, a continuous solid carbon fractionation system that thermally cracks coal without combustion. The process separates coal into its constituent components, including diesel, naphtha, hydrogen, fertilizer, sulfuric acid and solid carbon, and captures sulfur compounds before they reach the final carbon product. The process removes more than 90% of sulfur from the coal, and the result is a carbon material with sulfur content below 1%.

That specification matters in practical terms. Steel manufacturers using carbon as a recarburizing agent, or adding carbon back into molten metal to hit precise carbon content targets, need a consistent, low-contamination product. High sulfur in the carbon means high sulfur in the steel, which weakens the material and can require additional processing to correct. FASCarbon’s low sulfur content makes it a direct substitute for higher-grade, more expensive carbon inputs in steelmaking and industrial heating applications.

FASCarbon is not a product Frontieras developed alongside its fuel and chemical outputs as an afterthought. The proprietary platform carries its own commercial weight within the FASForm system. At the company’s planned Mason County, West Virginia facility, which will process 7,500 tons of coal per day, FASCarbon will be produced alongside diesel, naphtha, jet fuel, ammonium sulfate fertilizer and sulfuric acid. Every output has a defined market. The carbon product slots into steel, cement and industrial fuel applications that already have established buyers, pricing mechanisms and distribution infrastructure.

The steel and heavy industry markets that FASCarbon targets are not waiting for a new generation of technology to arrive. They are operating today, consuming carbon inputs at scale, and paying a premium for lower-sulfur grades that meet their quality requirements. Frontieras is building a facility that produces exactly that product, from domestic feedstock, at a U.S. location, with no reliance on imported material or overseas processing.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• SPARC AI is expanding its push into the U.S. public safety market with GPS-independent target acquisition and navigation technology designed for drones and other autonomous systems.
• The company has established a dedicated U.S. Federal and Public Safety team focused on customer engagement, demonstrations, evaluations, systems integration and government procurement pathways.
• The new team is intended to help move Overwatch from field evaluations toward operational adoption across law enforcement, border security, search and rescue, disaster response and critical-infrastructure missions.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is developing software designed to give drones and other autonomous systems targeting and navigation capabilities without relying on GPS. As interference and denial become increasingly relevant across defense and public-safety environments, the company is positioning its technology around a straightforward challenge: maintaining accurate positioning and target acquisition when conventional satellite navigation is unavailable or unreliable.

SPARC AI’s technology portfolio includes a Target Acquisition System designed to determine the geolocation of visible objects using camera telemetry and advanced mathematical modeling. Its SPARC AI Mobile technology extends those capabilities to handheld devices, allowing operators to identify and transmit coordinates to connected drones, while its GPS-Denied Navigation technology supports mission planning and execution without GPS.

These capabilities are brought together through Overwatch, the company’s mission-ready platform for real-time classification, detection, tracking, target acquisition and navigation. The software-based system is designed to provide autonomous systems with positioning and targeting capabilities in environments where GPS signals may be limited or unavailable.

Building a Path from Evaluation to Deployment

The technology itself is only one part of the commercialization challenge. For government and public-safety customers, moving from a successful demonstration to operational deployment can require field testing, integration, procurement support and continued engagement with end users.

SPARC AI is now building infrastructure around that process.

The company recently announced the establishment and initial buildout of a dedicated U.S. Federal and Public Safety team focused on expanding Overwatch within government and mission-critical markets. The team will advance customer engagement, coordinate field demonstrations and evaluations, develop relationships with systems integrators and OEM partners, support government procurement pathways and help convert successful Overwatch evaluations into operational adoption.

It will also work with SPARC AI’s engineering and integration teams to incorporate operator feedback and mission requirements into product-development priorities.

The company has secured a senior commercial leader to oversee federal and public-safety sales while coordinating capabilities across integration engineering, customer engagement and government contracting support.

Targeting GPS-Denied Missions

The team’s initial focus includes law enforcement and border security, disaster response, search and rescue, and critical-infrastructure monitoring. These applications share a common requirement: teams may need accurate positioning and target information even when GPS is unavailable, unreliable or disrupted.

SPARC AI’s software-only approach is designed to address that challenge without requiring specialized hardware or external data feeds. By using camera telemetry, mathematical modeling and software-based processing, the company aims to provide positioning and target-acquisition capabilities across existing platforms.

For public-safety organizations, that could be particularly relevant when infrastructure is damaged, communications are degraded or satellite-navigation signals cannot be trusted.

The opportunity also extends beyond individual drones. If Overwatch can be integrated across different robotic platforms and operational environments, the same underlying technology could potentially support a range of missions requiring accurate positioning and target acquisition without dependable GPS.

Moving Toward Broader Adoption

The establishment of the Federal and Public Safety team represents a step forward in SPARC AI’s commercialization strategy. The company is not only demonstrating what GPS-independent technology can do, but also building the customer, integration and procurement infrastructure needed to support adoption.

That distinction is important in defense and public safety, where a successful technology demonstration does not automatically translate into operational deployment. Systems must meet mission requirements, integrate with existing workflows and platforms, and navigate established procurement processes.

SPARC AI’s new team is designed to support that transition while feeding operator feedback back into product development.

As drones and autonomous systems become increasingly important to surveillance, reconnaissance, emergency response and security operations, the ability to maintain reliable positioning outside conventional GPS environments could become increasingly valuable.

SPARC AI is positioning Overwatch around that challenge while building a dedicated U.S. organization to pursue federal and public-safety opportunities. If the company can convert evaluations into repeatable operational deployments, the initiative could mark an important transition from technology validation toward broader adoption.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

• Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct the preclinical validation needed to determine the program’s next development steps.
• VXA-222 uses an “AND-gate” approach designed to recognize two tumor-associated antigens simultaneously before delivering its therapeutic payload.
• The company has separately filed its first patents related to its BiTAC-TCE and BiTAC-ADC platforms while expanding protection around antibody conjugation and payload technologies.
• The company is building a diversified oncology pipeline spanning bispecific T-cell engagers, ADCs, and other engineered antibody formats.

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has moved its VXA-222 bispecific antibody-drug conjugate program into the next stage of development after completing the initial phase of its collaboration with OmniAb, giving the biotechnology company a new development milestone while it continues expanding the intellectual-property estate underpinning its antibody technology portfolio.

According to a Yahoo Finance report, VERAXA will now take the antibody binders generated through the OmniAb collaboration and use its own antibody engineering, linker and conjugation technologies to construct the final VXA-222 candidate. The company will then conduct in vitro and in vivo studies as part of the preclinical validation process (https://ibn.fm/jR6JV).

The development update comes as VERAXA pursues a broader oncology strategy that includes antibody-drug conjugates, T-cell engagers and engineered antibody formats. VERAXA’s corporate materials outline a technology-focused approach to antibody therapeutics, with the company developing programs both around its proprietary BiTAC platform and through other antibody-engineering technologies.

The VXA-222 program originated from a collaboration with OmniAb that began in May 2025. Under the arrangement, OmniAb applied its antibody-discovery capabilities to generate therapeutic antibody binders suitable for development into a bispecific ADC.

OmniAb’s contribution included its OmniClic(TM) transgenic chicken technology, which is designed to generate common-light-chain antibodies that can be used in bispecific therapeutics. The discovery program produced a portfolio of human antibody candidates that underwent affinity maturation.

With that phase completed, responsibility for the next stage shifts to VERAXA. The company plans to combine the selected binders with its proprietary antibody engineering, linker and conjugation technologies. The objective is to produce the final bispecific antibody-drug conjugate candidate and then evaluate its performance through laboratory and animal studies.

VXA-222 is designed around an “AND-gate” mechanism. Instead of relying on recognition of a single tumor-associated antigen, the bispecific molecule is intended to recognize two separate targets simultaneously. The rationale is that requiring both targets to be present could increase selectivity for cancer cells while reducing exposure to healthy tissue. 

The VXA-222 milestone coincides with another area of activity that is particularly relevant to a development-stage biotechnology company: intellectual property. On July 29, VERAXA announced its first patent filings covering its newest BiTAC technology platforms, including BiTAC-TCE and BiTAC-ADC programs.

The filings cover more than individual drug candidates. According to the company, the applications include composition-of-matter claims, proprietary payload technologies and elements of the underlying antibody-engineering platforms. Additional intellectual-property work covers enabling technologies such as click chemistry and conjugation methods. VERAXA said certain patent applications involving these technologies have also completed their opposition periods.

The company now reports more than 50 granted patents that it either owns or exclusively licenses, spanning 26 patent families in 14 countries. Newly filed applications, if ultimately granted, are expected to extend protection for portions of its technology portfolio through at least 2047.

A significant portion of the company’s intellectual-property strategy is focused on its BiTAC platform. VERAXA describes BiTAC as a molecular architecture designed to increase tumor selectivity through dual-target recognition. The underlying concept is to require interaction with two cancer-associated targets before the therapeutic mechanism becomes active.

The company’s BiTAC-TCE approach applies this concept to T-cell engagers. The BiTAC-TCE approach splits a TCE into two complementary antibody components whereby each component alone retains the ability to bind its tumor target, but its CD3-engaging activity remains switched off. Full cytotoxic activity is triggered only when both components co-localize on a single cell, meaning a cancer cell that expresses both intended target antigens.

Its BiTAC-ADC approach uses two antibody components that independently deliver inactive components, which are intended to become therapeutically active through a specific click-to-release chemical reaction inside targeted tumor cells.

These approaches are being developed with the goal of limiting activity outside tumors while addressing technical considerations associated with conventional antibody-based therapies.

The broader antibody-drug conjugate market has attracted substantial pharmaceutical investment because ADCs combine the targeting properties of antibodies with potent therapeutic payloads. Bispecific formats add another layer by allowing a therapy to recognize multiple biological targets.

VERAXA’s strategy is therefore not dependent on a single molecular format. The company’s pipeline includes conventional and bispecific ADC programs alongside T-cell engagers and other engineered antibody candidates. 

For more information, visit the company’s website at www.Veraxa.com.

NOTE TO INVESTORS: The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA

• The United States sits on a significant coal resource base.
• FASForm produces six commercial outputs from a single coal input: diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid and FASCarbon(TM).
• Frontieras is moving this technology from development into construction.

The Strait of Hormuz closure that began in late February 2026 removed more than 11 million barrels of Middle Eastern crude per day from global markets and sent Brent crude from roughly $62 a barrel in December 2025 to more than $117 by April 2026. Diesel and jet fuel wholesale prices are forecast to rise more than 60% in 2026 compared to preconflict projections. The disruption has made one argument hard to ignore: Energy systems built around imported feedstocks and foreign supply chains are exposed to risks that domestic production does not carry. Frontieras North America is a company built on exactly that premise. Its patented FASForm(TM) technology converts domestic coal into diesel, naphtha, jet fuel, hydrogen, FASCarbon(TM), ammonium sulfate fertilizer and sulfuric acid using a feedstock that is abundant, domestically produced and priced independently of global oil markets.

The United States sits on a significant coal resource base. According to the U.S. Energy Information Administration (“EIA”), as of January 1, 2025, the country’s demonstrated reserve base contained approximately 468 billion short tons of coal, a resource larger than remaining U.S. natural gas and oil combined when measured by energy content. The country currently produces roughly 500 million short tons annually and has capacity well in excess of what combustion markets currently consume. That gap between what the ground holds and what existing applications use represents the core opportunity Frontieras is pursuing.

Coal has one property that makes it particularly useful as a feedstock for domestic fuel production: Its price does not move with crude oil. FASForm generates liquid transportation fuels from coal through a continuous thermal cracking and distillation process; no combustion, no water input, no CO2 is produced in the process itself. What is produced is 2.3 barrels of liquid fuels from each ton of coal processed, and because operating costs are independent of oil prices, margins grow as crude rises. In a market where diesel wholesale prices are surging past 60% above prior forecasts, a domestic fuel production system anchored to coal feedstock costs rather than Brent crude represents a structurally different risk profile.

FASForm produces six commercial outputs from a single coal input: diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid, and FASCarbon, a low-sulfur industrial carbon product. None of these require foreign feedstocks or overseas processing. The fertilizer output is particularly timely. The same Strait of Hormuz disruption that spiked oil prices also cut off urea and fertilizer flows that pass through Middle Eastern shipping lanes, raising food-security concerns alongside energy-security worries. FASForm captures and repurposes the ammonia and sulfur compounds released during coal fractionation into ammonium sulfate fertilizer, a product with established domestic demand that, from a Frontieras facility, would be produced entirely within U.S. supply chains.

The process operates as a closed-loop system. Frontieras describes it as zero waste: The volatiles, moisture and contaminants extracted from coal during fractionation are captured and repurposed or sold to buyers or in the spot market rather than released. Sulfur is removed from the coal stream and converted into sulfuric acid. Mercury and arsenic are eliminated. And at the West Virginia facility, water extracted during fractionation will be filtered and returned to the Ohio River.

Frontieras is moving this technology from development into construction. In January 2026, West Virginia Governor Patrick Morrisey announced that Frontieras had closed on 183 acres in Mason County, where the company will build its first commercial-scale FASForm facility. The investment is estimated at $850 million. The company hosted a groundbreaking ceremony for the plant earlier this year and is moving forward with plans to build the facility.

“This groundbreaking marks a decisive step in the commercialization of FASForm and the return of serious industrial investment to America’s energy regions,” said Frontieras CEO and cofounder Matthew McKean. “We’re building a new class of energy infrastructure that extracts maximum value from domestic resources — profitably, at scale, and with a zero-waste design.” 

The West-Virginia project is expected to create more than 2,000 construction jobs and 200-plus permanent positions. Frontieras selected Mason County over competing sites in Texas and Wyoming, citing West Virginia’s infrastructure, logistics advantages and energy-friendly regulatory environment. 

Each FASForm facility is designed to process 7,500 tons of coal per day, or roughly 2.7 million tons annually. That represents approximately 0.5% of U.S. annual coal production per facility. The math suggests significant room for expansion without straining domestic supply. The company holds patents in nine countries across five continents, covering an estimated 85% of global coal markets. The technology’s combined addressable markets — spanning fuels, hydrogen, fertilizer and industrial chemicals — are estimated by the company at more than $2.1 trillion.

The broader energy policy environment is shifting in ways that favor this kind of domestic production model. The EIA’s June 2026 Short-Term Energy Outlook notes that disruptions to crude oil and refined product flows through the Strait of Hormuz have increased demand for U.S. supply. Deloitte’s 2026 oil and gas industry outlook identifies supply chain resilience as a defining priority, noting that ongoing disruptions are driving industries to favor domestic or nontariffed suppliers over lowest-cost foreign sourcing. Frontieras is producing fuels and materials from a feedstock that never leaves the country, a supply chain that geopolitical disruption cannot reach.

Coal’s value as an industrial feedstock has been largely bypassed in favor of its simpler use as a combustion fuel. Frontieras is built on the argument that this is a enormous missed opportunity. The company’s FASForm platform treats coal the way a refinery treats crude oil: as a complex hydrocarbon resource to be separated into its most valuable constituent parts. What comes out the other end is not emissions but products: fuel for trucks and aircraft, hydrogen for industrial processes, fertilizer for farms and carbon materials for manufacturing. These are markets the United States currently depends on foreign suppliers to fill. Frontieras is working to change that, from the ground up, using a resource the country already has in abundance. 

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

• WRAP is using newly raised $12 million in growth capital to support planned business expansion and accelerate development of its WrapShield(TM) platform.
• The company is connecting technologies spanning detection, response, training and evidence management as it expands beyond traditional law enforcement into enterprise, federal, defense and international markets.
• WRAP’s growing technology portfolio and strategic partnerships position WrapShield(TM) as an architecture designed to bring multiple public safety capabilities together under a unified platform.

Public safety agencies are increasingly confronting a technology environment in which detection, response, training and digital evidence must work together rather than operate as isolated systems. As agencies modernize their operations, the opportunity is expanding beyond individual products toward connected platforms capable of supporting multiple stages of the public safety workflow.

Wrap Technologies (NASDAQ: WRAP) is positioning itself around that shift through WrapShield(TM), an expanding technology architecture designed to connect detection, decision-making and proportionate response across public safety and security applications.

The strategy represents a broader evolution of WRAP’s business. The company’s portfolio includes BolaWrap(R) 150, WRAP Vision(TM), WRAP Tactics(TM) and WRAP Reality(TM), providing capabilities spanning non-lethal response, digital evidence management and officer training. Rather than treating these technologies as standalone offerings, WRAP is working to integrate them into a broader platform capable of addressing multiple operational requirements.

That strategy received additional financial support on Aug. 18, when WRAP closed an equity offering that raised approximately $12 million in growth capital from institutional investors. According to the company, the funds are intended for working capital and general business purposes, including planned expansion that may accelerate WrapShield(TM), scale its public safety business and support opportunities across enterprise safety, U.S. federal and defense markets and international markets.

The capital comes as WRAP expands the potential scope of WrapShield(TM) beyond traditional law enforcement. The company says the architecture is being developed to incorporate technologies including advanced remote sensing, passive RF detection, counter-UAS capabilities and emerging detection and response technologies. Its relationship with Frenel Imaging also provides access to thermal polarimetric imaging technology that WRAP says could support applications ranging from early threat detection and counter-UAS to public safety and critical infrastructure.

This broader approach could give WRAP multiple avenues for commercialization. Technologies developed for one environment may have applications across law enforcement, enterprise security, critical infrastructure, major-event protection and federal or defense markets, allowing the company to pursue opportunities beyond the traditional market for non-lethal policing equipment.

WRAP is also expanding its potential customer base beyond government agencies. The company’s developing relationship with XINSURANCE is intended to support opportunities in enterprise safety, private security and insurance-supported programs, potentially introducing WRAP’s technologies to commercial organizations with broader workforce and security requirements.

For investors, the significance of this strategy lies in the potential transition from a product-focused public safety company toward a more diversified technology platform. Hardware such as BolaWrap(R) 150 remains an important component, but combining response technologies with training, evidence management, sensing and software could create opportunities for deeper relationships with agencies and organizations.

WRAP’s recent financing provides additional resources as the company pursues that expansion. At the same time, the company’s reported second-quarter revenue momentum, expanding product portfolio and growing technology pipeline provide a foundation for its efforts to scale the business.

The evolution of WrapShield(TM) ultimately reflects a larger change taking place across public safety and security technology. Agencies, enterprises and government organizations are increasingly looking for systems capable of connecting information, trained personnel and appropriate response rather than relying on disconnected tools. By bringing together detection, evidence management, training and proportionate response, WRAP is positioning WrapShield(TM) to participate in that broader convergence while pursuing opportunities across public safety, enterprise, federal, defense and international markets.

For more information, visit the company’s website at Wrap.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies Inc. or its management, including any forward-looking statements regarding revenue growth, product development, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• GPS jamming and spoofing have evolved from isolated battlefield threats into a broader operational challenge for military and autonomous systems.
• SPARC AI’s software-first approach is designed to provide target acquisition and navigation capabilities without relying on GPS or active sensing hardware.
• Integrations with existing drone platforms and software ecosystems could allow operators to add GPS-independent capabilities without replacing entire fleets.

Modern militaries have built decades of doctrine around the assumption that satellite navigation would remain available when needed, but that assumption is increasingly being challenged in real-world operations. Drone operators can have clear video feed while the coordinates associated with that imagery have been corrupted by jamming or spoofing, creating what the defense industry has started calling targeting paralysis. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) has spent years developing software designed to address this vulnerability, enabling drones and edge devices to acquire targets and navigate without depending on GPS.

The scale of the jamming and spoofing problem has grown well beyond isolated incidents. The war between Russia and Ukraine has become a live testing ground for electronic warfare, with jamming and anti-jamming systems deployed extensively across the battlefield. Ukraine has also developed a nationwide spoofing defense network known as Pokrova to help protect cities, energy infrastructure and military facilities. At the same time, Ukrainian forces are fielding GPS-independent visual navigation systems, illustrating how quickly alternatives to satellite positioning are moving from specialized capabilities toward practical battlefield requirements. The broader lesson is becoming increasingly difficult to ignore GPS denial is no longer simply a contingency that militaries prepare for; it is an operational reality that increasingly shapes how autonomous systems are designed and deployed.

United States defense planners are reaching a similar conclusion. In July 2026, the Air Force Research Laboratory committed $49.7 million to a program aimed at maturing alternative satellite navigation technologies through 2031, raising the importance of navigation capabilities that can operate when GPS is disrupted or unavailable. Investment at that scale reflects a shift in how militaries and public-safety agencies approach navigation, with GPS increasingly viewed not as an unquestioned default but as one input among several that can be degraded, denied or manipulated.

SPARC AI approaches that shift from the software side rather than through new hardware. Its core technology, called Spatial Predictive Approximation and Radial Convolution, is designed to turn sensors, cameras and smartphones into target coordinate acquisition systems. The company describes the technology as a zero-signature approach because it does not depend on radar, lidar or other active emissions that could reveal a platform’s position to an adversary. That software-first architecture could be particularly relevant as military and autonomous-system operators look for ways to add GPS resilience without rebuilding the hardware platforms already in service.

That architecture runs across a growing suite of products rather than a single application. The company’s Overwatch platform provides real-time detection, tracking and target acquisition for drones and autonomous systems operating in signal-contested environments. Its ATLAS module, designed for mission planning, performs visibility and line-of-sight simulations entirely in software, reducing the need for active sensing hardware traditionally associated with terrain mapping. SPARC AI Mobile extends the same capability to handheld devices, running on a defense-grade smartphone to provide offline GPS-denied navigation and camera-based target identification without a laser range finder. Together, the platforms illustrate SPARC AI’s broader effort to deliver GPS-independent capabilities across multiple layers of the autonomous and defense technology stack.

Interoperability has also been central to the company’s development strategy. SPARC AI has built a Universal API that allows organizations to integrate Overwatch directly into existing drone hardware, and has also integrated with QGroundControl, a widely used open-source ground station supporting drone systems built around the PX4 and ArduPilot autopilots. These integrations lower the barrier for operators seeking to add GPS-independent capabilities to existing fleets rather than replace them entirely. In a fragmented drone market, where operators may be reluctant to discard proven hardware simply to gain greater GPS resilience, a software layer that can work across existing systems could provide an important commercial advantage.

Software alone does not reach military and public-safety customers without a path to market, and SPARC AI has spent the past year developing that side of the business as well. Late in 2025, the company signed a nonexclusive reseller agreement with a defense integrator with more than four decades of experience and offices across Europe, the United States and Australia. The arrangement gives SPARC AI access to established procurement relationships in several strategically important markets and covers the company’s target acquisition systems, autonomous navigation technology and Overwatch platform.

More recently, SPARC AI added a second drone manufacturer in Ukraine to its Overwatch platform, following earlier integrations with a manufacturer in India and a partner working with defense officials in the United Arab Emirates. Beyond expanding the potential reach of the platform, deployments across different drone systems can provide additional real-world operating data that may help inform future software development. That practical exposure is particularly relevant in GPS-denied navigation, where performance under contested conditions ultimately matters more than laboratory demonstrations alone.

As governments and defense integrators increasingly treat GPS denial as a baseline planning consideration rather than an edge case, demand for navigation and targeting capabilities that can operate independently of satellite positioning could continue to expand. SPARC AI’s software-first, hardware-agnostic approach gives the company a way to participate in that transition without requiring operators to replace the underlying platforms already in service. Combined with integrations across existing drone ecosystems, international partnerships and growing exposure to real-world deployments, the company’s strategy reflects a broader move toward making GPS resilience an integrated capability rather than a specialized add-on.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF